Citation Impact
Citing Papers
Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome
2010
Pathway Analysis Based on a Genome-Wide Association Study of Polycystic Ovary Syndrome
2015
Testosterone-induced downregulation of anti-Müllerian hormone expression in granulosa cells from small bovine follicles
2009
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
2010 Standout
Recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome
2018 Standout
Structure of the PAPP-ABP5 complex reveals mechanism of substrate recognition
2022 StandoutNobel
The effects of oxidative stress on female reproduction: a review
2012 Standout
Anti-Müllerian hormone (AMH): Regulator and marker of ovarian function
2010
Thiazolidinediones
2004 Standout
Follicle dynamics and anovulation in polycystic ovary syndrome
2008
Serum anti-Mullerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation
2010
Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study
2005
Comparison of serum anti-Müllerian hormone levels in normal weight and overweight–obese adolescent patients with polycystic ovary syndrome
2014
Luteinizing Hormone Receptor, Steroidogenesis Acute Regulatory Protein, and Steroidogenic Enzyme Messenger Ribonucleic Acids Are Overexpressed in Thecal and Granulosa Cells from Polycystic Ovaries1
2001
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
2014
Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
2011
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Formation and early development of follicles in the polycystic ovary
2003
The physiology and clinical utility of anti-Müllerian hormone in women
2014 Standout
Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome
2008
Molecular mechanisms of insulin resistance in polycystic ovary syndrome
2006
The management of patients with polycystic ovary syndrome
2014
Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-müllerian hormone and inhibin-B
2007
Biomedical applications of biodegradable polymers
2011 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Anti-Müllerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels
2008
Follicular dynamics in the polycystic ovary syndrome
2000
Is polycystic ovary syndrome an exception for reproductive aging?
2010
Polycystic ovary syndrome and its developmental origins
2007
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Serum Anti-Müllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum Follicle Stimulating Hormone (FSH) levels
2011
Obesity and polycystic ovary syndrome
2006
Physical properties of alginate hydrogels and their effects on in vitro follicle development
2007
Fertility and infertility: Definition and epidemiology
2018 Standout
The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest
2004
Is foetal hyperexposure to androgens a cause of PCOS?
2017
Acne vulgaris
2011 Standout
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
2011
Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries
2004
Insulin-like growth factor binding proteins 4-6
2015
Polycystic Ovary Syndrome and Oocyte Developmental Competence
2008
Executive summary of the Stages of Reproductive Aging Workshop + 10
2012 Standout
Polycystic Ovary Syndrome
2005 Standout
Insulin and insulin resistance:
2004 Standout
Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features
2012
Anti-Müllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells
2011
Developmental origin of polycystic ovary syndrome - a hypothesis
2002
Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?
2016
The Metabolic Syndrome in Polycystic Ovary Syndrome
2007
Drug Insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome—a reappraisal
2008
Polycystic ovary syndrome
1997
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Assessment and management of anovulatory infertility in polycystic ovary syndrome
2003
INSULIN ACTION IN THE NORMAL AND POLYCYSTIC OVARY
1999
Anti-Mullerian hormone (AMH): what do we still need to know?
2009
The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance
2008
Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?
2012
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
2009
Loss of LH-induced down-regulation of anti-Mullerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome
2013
Polycystic ovary syndrome
2016 Standout
Polycystic ovary syndrome in adolescents
2008
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
2011 Standout
Polycystic Ovary Syndrome in Adolescence
2005
Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries
2012
Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients
2010
Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters
2011
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Interpreting human follicular recruitment and antimüllerian hormone concentrations throughout life
2012
Anti-Müllerian hormone and ovarian dysfunction
2008
PCOS Forum: research in polycystic ovary syndrome today and tomorrow
2010
Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.
1976 Standout
Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
2008
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies
2011 Standout
Anti-MüLlerian Hormone as a Marker of Ovarian Reserve: An Update
2008
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Health Consequences of Obesity in Youth: Childhood Predictors of Adult Disease
1998 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
The Insulin-Related Ovarian Regulatory System in Health and Disease
1999
40 YEARS OF IGF1: IGF-binding proteins
2017
Role of Oxidative Stress in Polycystic Ovary Syndrome
2010
Variations in the Pattern of Pubertal Changes in Boys
1970 Standout
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Serum Anti-Mullerian Hormone Concentrations Are Elevated in Oligomenorrheic Girls without Evidence of Hyperandrogenism
2010
Early onset adiposity: a pathway to polycystic ovary syndrome in adolescents?
2007
Hormonal Profile in Women with Polycystic Ovarian Syndrome with or without Type 1 Diabetes Mellitus
2007
Interrelationships between Ovarian and Pituitary Hormones in Ovulatory Menstrual Cycles across Reproductive Age
2008
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
2015
The use of metformin for women with PCOS undergoing IVF treatment
2006
Early origins of polycystic ovary syndrome
2005
Combined Lifestyle Modification and Metformin in Obese Patients with Polycystic Ovary Syndrome: A Randomized, Placebo-controlled, Double-blind Multicentre Study
2006
The Timing of Normal Puberty and the Age Limits of Sexual Precocity: Variations around the World, Secular Trends, and Changes after Migration
2003 Standout
Prospective Parallel Randomized, Double-Blind, Double-Dummy Controlled Clinical Trial Comparing Clomiphene Citrate and Metformin as the First-Line Treatment for Ovulation Induction in Nonobese Anovulatory Women with Polycystic Ovary Syndrome
2005
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Changes in Serum Anti-Mullerian Hormone Level during Low-Dose Recombinant Follicular-Stimulating Hormone Therapy for Anovulation in Polycystic Ovary Syndrome
2007
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
2016
Anti-Mullerian Hormone, Its Receptor, FSH Receptor, and Androgen Receptor Genes Are Overexpressed by Granulosa Cells from Stimulated Follicles in Women with Polycystic Ovary Syndrome
2008
Prolonged Survival in Culture of Preantral Follicles from Polycystic Ovaries
2007
Works of Ray Galea being referenced
Insulin-Like Growth Factor (IGF)-Independent Effects of IGF Binding Protein-4 on Human Granulosa Cell Steroidogenesis1
2002
Granulosa Cell Production of Anti-Müllerian Hormone Is Increased in Polycystic Ovaries
2006
Metformin has direct effects on human ovarian steroidogenesis
2003
Premature Response to Luteinizing Hormone of Granulosa Cells from Anovulatory Women with Polycystic Ovary Syndrome: Relevance to Mechanism of Anovulation1
1998